Gene Expression Profiling Predicts the Development of Oral Cancer
暂无分享,去创建一个
Li Mao | Edward S. Kim | Pierre Saintigny | Li Zhang | J. Lee | A. El‐Naggar | L. Mao | V. Papadimitrakopoulou | P. Saintigny | Lei Feng | W. Ki Hong | Li Zhang | Youhong Fan | Adel K. El-Naggar | Lei Feng | You-Hong Fan | Vassiliki A. Papadimitrakopoulou | Waun Ki Hong | J. Jack Lee | Li Mao | A. El-Naggar | Lei Feng | J. Lee | W. Hong
[1] S. Tickoo,et al. Oral Cavity and Esophageal Carcinogenesis Modeled in Carcinogen-Treated Mice , 2004, Clinical Cancer Research.
[2] V. Castronovo,et al. Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer , 2008, Nature Reviews Cancer.
[3] S. Dudoit,et al. Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data , 2002 .
[4] D. Felsher,et al. MYC as a regulator of ribosome biogenesis and protein synthesis , 2010, Nature Reviews Cancer.
[5] C. Perou,et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression , 2004 .
[6] Li Mao,et al. Transcriptomic dissection of tongue squamous cell carcinoma , 2008, BMC Genomics.
[7] C. Morrison,et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.
[8] David Sidransky,et al. The Oral Cavity as a Molecular Mirror of Lung Carcinogenesis , 2008, Cancer Prevention Research.
[9] Harald Binder,et al. Boosting for high-dimensional time-to-event data with competing risks , 2009, Bioinform..
[10] Simon Talbot,et al. Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis , 2009, BMC Cancer.
[11] A. Elkahloun,et al. A Novel Nuclear Factor-κB Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status , 2007, Clinical Cancer Research.
[12] R. Tibshirani,et al. Improvements on Cross-Validation: The 632+ Bootstrap Method , 1997 .
[13] Yan Zeng,et al. Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 2008, Carcinogenesis.
[14] E. Spisni,et al. MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. , 2009, Experimental cell research.
[15] J. Grandis,et al. Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death , 2009, Molecular Cancer Therapeutics.
[16] John Quackenbush,et al. Open source software for the analysis of microarray data. , 2003, BioTechniques.
[17] N. Fusenig,et al. Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.
[18] Anne-Mette K. Hein,et al. Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study , 2007, Clinical Cancer Research.
[19] P. Sebastiani,et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer , 2007, Nature Medicine.
[20] D. Jablons,et al. Unmet need in lung cancer: can vaccines bridge the gap? , 2008, Clinical lung cancer.
[21] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Wersäll,et al. Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa , 1967, Cancer.
[23] Edward S. Kim,et al. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Patricia Soteropoulos,et al. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. , 2004, Cancer genetics and cytogenetics.
[25] Richard Simon,et al. Gene expression-based prognostic signatures in lung cancer: ready for clinical use? , 2010, Journal of the National Cancer Institute.
[26] S. Varambally,et al. Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer , 2008, Science.
[27] K. Coombes,et al. Microarrays: retracing steps , 2007, Nature Medicine.
[28] H. Ovaa,et al. CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib. , 2008, Blood.
[29] Stan Pounds,et al. Estimating the Occurrence of False Positives and False Negatives in Microarray Studies by Approximating and Partitioning the Empirical Distribution of P-values , 2003, Bioinform..
[30] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[31] Stuart M. Brown,et al. Selection and validation of differentially expressed genes in head and neck cancer , 2004, Cellular and Molecular Life Sciences CMLS.
[32] Shuji Ogino,et al. DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer , 2009, Clinical Cancer Research.
[33] A. Seth,et al. The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications. , 2004, European journal of cancer.
[34] Xi Chen,et al. An Integrative Pathway-based Clinical-genomic Model for Cancer Survival Prediction. , 2010, Statistics & probability letters.
[35] Igor Jurisica,et al. Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study , 2008, Nature Medicine.
[36] David I. Smith,et al. Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. , 2008, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[37] Edward S. Kim,et al. Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] R. Warnke,et al. Immune signatures in follicular lymphoma. , 2005, The New England journal of medicine.
[39] Edward S. Kim,et al. Epidermal Growth Factor Receptor Expression and Gene Copy Number in the Risk of Oral Cancer , 2010, Cancer Prevention Research.
[40] Edward S. Kim,et al. Oral Epithelium as a Surrogate Tissue for Assessing Smoking-Induced Molecular Alterations in the Lungs , 2008, Cancer Prevention Research.
[41] M. Newton,et al. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. , 2007, Cancer research.
[42] Olivier Poch,et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis , 2004, Oncogene.
[43] Giovanni Castagnetti,et al. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. , 2006, Cancer research.
[44] S. Warnakulasuriya,et al. Nomenclature and classification of potentially malignant disorders of the oral mucosa. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[45] Edward S. Kim,et al. ΔNp63 Overexpression, Alone and in Combination with Other Biomarkers, Predicts the Development of Oral Cancer in Patients with Leukoplakia , 2009, Clinical Cancer Research.
[46] Q. Wei,et al. Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: a case-control study. , 2008, Cancer letters.
[47] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[48] S. Lippman,et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment , 1996, Nature Medicine.
[49] C. Perou,et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. , 2004, Cancer cell.
[50] Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner. , 2007, Cancer research.
[51] Diane D. Liu,et al. Phase II Randomized, Placebo-Controlled Trial of Green Tea Extract in Patients with High-Risk Oral Premalignant Lesions , 2009, Cancer Prevention Research.
[52] Q. Dou,et al. Clinical development of novel proteasome inhibitors for cancer treatment , 2009, Expert opinion on investigational drugs.
[53] H. Ackermann,et al. Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines , 2009, Journal of Cancer Research and Clinical Oncology.
[54] M. Gorsky,et al. Oral leukoplakia and malignant transformation. A follow‐up study of 257 patients , 1984, Cancer.
[55] H. Hsu,et al. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. , 2007, Lung cancer.
[56] S. Lippman,et al. Predicting cancer development in oral leukoplakia: ten years of translational research. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.